Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Andrx Completes Divestiture of Fortamet and Altoprev to First Horizon Pharmaceutical Corporation.


FORT LAUDERDALE Fort Lauderdale (lô`dərdāl), residential, commercial, and resort city (1990 pop. 149,377), seat of Broward co., SE Fla., on the Atlantic coast; settled around a fort built (c.1837) in the Seminole War, inc. 1911. , Fla. -- Andrx Corporation (Nasdaq:ADRX ADRX Andrx Corporation (stock symbol) ) ("Andrx") today announced that it has completed its previously announced sale and licensing of certain rights and assets related to its Fortamet(R) and Altoprev(R) brand pharmaceutical products to First Horizon Pharmaceutical(R) Corporation ("First Horizon").

Andrx received $50 million for Fortamet at the closing. Andrx is entitled to receive up to $35 million in additional proceeds for Altoprev, once it achieves certain defined manufacturing service levels for this product set forth in the agreement. Andrx expects to receive $23.3 million of such amount in connection with the first such delivery scheduled for this week. Andrx will also receive royalties on net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
, as defined, of 8% on Fortamet and 15% on Altoprev.

Thomas P. Rice, Andrx's Chief Executive Officer, said, "We are extremely pleased to complete this transaction with First Horizon and are confident that they are the right organization to optimize the value of the Fortamet and Altoprev products for the benefit of both our companies. Our future financial results will not be burdened by the significant operating losses operating loss

The excess of operating expenses over revenue. As with operating income, operating losses exclude revenues and expenses from operations that are not considered a regular part of the business. Also called deficit. Compare operating income.
 that we experienced in the brand business. This transaction will also better allow us to re-focus our efforts and resources on our core strengths of formulation development of generic controlled-release pharmaceuticals and distribution for the benefit of our shareholders."

About Andrx Corporation:

We are a pharmaceutical company that develops, manufactures and commercializes generic versions of controlled-release, niche and immediate-release pharmaceutical products, including oral contraceptives Oral Contraceptives Definition

Oral contraceptives are medicines taken by mouth to help prevent pregnancy. They are also known as the Pill, OCs, or birth control pills.
. We also distribute pharmaceuticals, primarily generics, which have been commercialized by others, as well as our own, primarily to independent pharmacies An independent pharmacy is a retail pharmacy that is not directly affiliated with any chain pharmacy, such as CVS/pharmacy, Walgreens or Eckerd. However, owners of independent pharmacies will often form alliances with other independents and use their power in numbers to bargain for , pharmacy chains, pharmacy buying groups and physicians' offices.

Forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 (statements which are not historical facts) in this release are made pursuant to the safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. For this purpose, any statements contained herein or which are otherwise made by or on behalf of the Company that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Investors are cautioned that all forward-looking statements involve risk and uncertainties, including but not limited to, the Company's ability to meet the supply and manufacturing requirements of the First Horizon agreement, the Company's dependence on a relatively small number of products, licensing revenues, the timing and outcome of litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 and future product launches, government regulation, competition, and manufacturing results. Andrx Corporation is also subject to other risks detailed herein or detailed from time to time in its filings with the U.S. Securities and Exchange Commission. Andrx disclaims any responsibility to update the statements contained herein.

This release and additional information about Andrx Corporation are also available on the Internet at: http://www.andrx.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 29, 2005
Words:487
Previous Article:Articulate Communications Inc. Named Second Fastest-Growing Independent PR Firm by O'Dwyer's.
Next Article:OrderMotion's New ''Swat Implementation'' Service Delivers Multi Channel Order Management Solution to Online Retailers within Five Days.
Topics:



Related Articles
Andrx Reports Fourth Quarter 2004 and Full Year Financial Results.
Andrx to Present at Lehman Brothers Annual Global Healthcare Conference.
First Horizon Announces Completion of Acquisition of Worldwide Rights to Fortamet and Altoprev from Andrx Corporation.
First Horizon Announces First-Quarter 2005 Earnings Release Date and Conference Call.
First Horizon Announces Results for the First Quarter Ended March 31, 2005 and Provides 2005 Guidance.
First Horizon to Present on May 3, 2005 at the Deutsche Bank Securities Inc. Health Care Conference.
Andrx Reports First Quarter 2005 Financial Results; Results Include $40 Million in Brand Disposition Charges, Including $26 Million of Goodwill, and...
First Horizon Pharmaceutical Corporation Announces That FDA Approves Triglide, a Novel Formulation of Fenofibrate.
First Horizon Announces Results for the Second Quarter and Six Months Ended June 30, 2005 and Updates 2005 Guidance.
Andrx Corporation Reports Financial Results for 2005 Fourth Quarter and Full Year.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles